Status:
UNKNOWN
Acupuncture Combined With Mirabegron in the Treatment of OAB
Lead Sponsor:
The Affiliated Ganzhou Hospital of Nanchang University
Conditions:
Overactive Bladder
Eligibility:
All Genders
14-75 years
Phase:
PHASE1
Brief Summary
Introduction: As conventional treatments for overactive bladder (OAB) have not yet shown satisfactory results, new approaches are needed. Therefore, this study aimed to investigate the efficacy and sa...
Eligibility Criteria
Inclusion
- Clinical diagnosis of OAB
- Good compliance
- Good communication skills
Exclusion
- Age \<14 or \>75 years
- History of use of M-blockers in the recent 4-6 weeks
- History of use of α-blockers in the recent 4-6 weeks
- History of use of mirabegron in the recent 4-6 weeks
- Diagnosis with a combined urinary tract tumor
- Inability to cooperate with this study
- Pregnancy
- Postvoid residual urine volume \>150 mL
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06181019
Start Date
December 1 2021
End Date
December 31 2024
Last Update
December 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ganzhou People's Hospital
Ganzhou, Jiangxi, China, 341000